IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm PortAI, I can summarize articles.
IDEXX Laboratories Inc. (IDXX) shares fell 1.10% to $632.56 on Tuesday, marking the sixth consecutive day of losses. The stock is now 17.85% below its 52-week high of $769.98. In contrast, competitors like Johnson & Johnson (JNJ) and Medtronic PLC (MDT) saw gains of 1.02% and 0.46%, respectively. The overall market also declined, with the S&P 500 down 0.84%. Trading volume for IDXX was 632,848, surpassing its 50-day average of 547,981.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments